Symptom burden among men treated for castration-resistant prostate cancer: a longitudinal study.

ABSTRACT:

Objectives

Despite rapid expansion of treatments for metastatic castration-resistant prostate cancer (mCRPC) and the importance of symptom management for enhancing quality of life, few studies have focused on men's experiences of symptom burden over time when receiving one or more lines of treatment in a real-world situation in this phase. The aim was to investigate changes in the multidimensional symptom burden during the first year of life-prolonging treatment of mCRPC.

Methods

Longitudinal data from the first year of life-prolonging treatment for 134 men with mCRPC were used. Symptoms were measured with the multidimensional Memorial Symptom Assessment Scale. Data are presented with descriptive statistics, and changes in symptom burden (physical, psychological and number o

SUBMITTER: Ronningas U 

PROVIDER: S-EPMC11874351 | biostudies-literature | 2024 Dec

REPOSITORIES: biostudies-literature